国医大师姚希贤诊治慢性肝病的学术思想

赵丽梅; 孙玉凤; 姚冬梅; 马俊骥

doi:10.3969/j.issn.1671-038X.2024.10.08

国医大师姚希贤诊治慢性肝病的学术思想

- 河北医科大学第二医院消化内科(石家庄，050000)

详细信息

通讯作者: 孙玉凤, E-mail: sunyfey@163.com

中图分类号: R575;R256.4

收稿日期: 2024-08-02

刊出日期: 2024-10-15

Master of traditional Chinese medicine YAO Xixian's clinical experience in the diagnosis and treatment of chronic liver disease

- Department of Gastroenterology, the Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China

More Information

Corresponding author: SUN Yufeng, E-mail: sunyfey@163.com

Received Date: 02 August 2024

Publish Date: 15 October 2024

摘要

摘要: 国医大师姚希贤教授从事中西医结合临床、科研及教学工作70余年，擅长运用中西医结合方法诊断治疗慢性肝病，以“瘀血证”立论，在临床积累的基础上进行了大量临床及实验研究，从临床到理论到实验，再到临床，积累了大量循证医学资料，形成了独特的学术思想与临证经验，创立了系统的“衷中笃西”理论体系。姚教授倡导的“中国医学”体系，是指发挥中医、西医、中西医结合的临床特点，取长补短，疗效为先，有机结合，进而打造具有中国特色的、以中医为主的中西医结合大医学体系。姚教授在“衷中笃西”思想的指导下，深入研习西医学对慢性肝病的认识，充分利用现代实验检查手段，拓展传统中医四诊的广度、深度和内涵，将现代医学关于慢性肝病的病因、病理、症状、诊断、鉴别、治疗、预后等资料进行整理分析，结合中医学理论及多年临床经验，以瘀血立论，同时顾护脾胃及正气，研制出治疗慢性肝病肝纤维化国家发明专利方剂“益肝康”，大量的临床、实验研究显示，该方可明显改善患者的临床症状，在治疗慢性肝病、肝纤维化、肝硬化方面疗效显著。
- 慢性肝病 /
- 中西医结合 /
- 瘀血证 /
- 姚希贤
Abstract: YAO Xixian, a master of traditional Chinese medicine (TCM), has dedicated over 70 years to clinical practice, scientific research and teaching in the field of integrated Chinese and Western medicine. He is committed to the diagnosis and treatment of chronic liver disease(CLD) with integrated Chinese and Western medicine. Over the years, based on theory of blood stasis and clinical accumulation, he has conducted a large number of clinical and experimental studies, from clinic to theory to experiment, then back to clinic. It has accumulated a large amount of evidence-based medical materials, forming a unique academic thought and clinical experience, and established a systematic theoretical system of "Zhong Zhong Du Xi". The "Chinese Medicine" system advocated by Professor YAO emphasizes leveraging the clinical strengths of both TCM and Western medicine, drawing on their respective advantages and complementing their weaknesses. Under the guidance of the "Zhong Zhong Du Xi" concept, Professor YAO has delved deeply into Western medicine's understanding of CLD. He has fully utilized modern experimental examination methods, thereby expanding the scope, depth, and connotation of TCM's four diagnostic methods. Furthermore, he has systematically analyzed modern medical data on the etiology, pathology, symptoms, diagnosis, differentiation, treatment, and prognosis of CLD. By combining TCM theory with his many years of clinical experience, and based on the theory of blood stasis, Professor YAO has developed the national invention patent prescription "Yigankang". This prescription, which also takes into account the spleen, stomach, and healthy Qi, is used for the treatment of CLD and liver fibrosis. Extensive clinical and experimental studies have demonstrated its ability to significantly improve patients' clinical symptoms and show marked efficacy in the treatment of CLD, liver fibrosis, and cirrhosis.
- chronic liver disease /
- integrated traditional Chinese and Western medicine /
- blood stasis syndrome /
- YAO Xixian

HTML全文

参考文献(22)

[1]	徐京杭, 于岩岩, 徐小元. 肝硬化临床研究进展[J]. 实用肝脏病杂志, 2024, 27(2): 161-164.
[2]	李青青, 杨红胜, 李金斗, 等. 肝纤维化发病机制及中医药抗肝纤维化的研究进展[J]. 江汉大学学报(自然科学版), 2023, 51(3): 75-81.
[3]	中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版)[J]. 中国中西医结合杂志, 2019, 39(11): 1286-1295.
[4]	余艳红, 于文明. 国医大师传承录-第三辑[M]. 北京: 中国中医药出版社, 2024: 741-744.
[5]	姚希贤. 衷中笃西内科病证治疗学[M]. 北京: 中国中医药出版社, 2021: 1-3.
[6]	苏春芝, 杨倩, 姚冬梅. 国医大师姚希贤肝病临证治验荟萃[M]. 郑州: 郑州大学出版社, 2024: 195-211.
[7]	姚洪森, 姚希贤, 姚冬梅, 等. 益肝康治疗慢性乙型肝炎肝纤维化365例疗效观察[J]. 临床荟萃, 2009, 24(8): 690-693.
[8]	孙玉凤, 姚希贤, 崔东来. 益肝浓缩煎剂抗肝纤维化的实验研究[J]. 中国中西医结合消化杂志, 2002, 10(2): 84-85, 88.
[9]	张纪勇, 油建萍. 阿德福韦酯联合益肝康治疗慢性乙型肝炎肝纤维化的疗效观察[J]. 中华消化病与影像杂志(电子版), 2014, 4(2): 91-93.
[10]	Yao XX, Tang YW, Yao DM, et al. Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells[J]. World J Gastroenterol, 2002, 8(3): 511-514. doi: 10.3748/wjg.v8.i3.511
[11]	中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41(1): 3-28.
[12]	姚希贤, 姚冬梅. 慢性肝炎肝纤维化中西医结合治疗问题[J]. 临床肝胆病杂志, 2013, 29(4): 245-248, 252.
[13]	中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志, 2019, 27(11): 846-865.
[14]	姚希贤. 衷中笃西消化病治疗学[M]. 北京: 中国中医药出版社, 2016: 165-169.
[15]	杨倩, 冯玉彦, 蒋树林. 姚希贤瘀血论治慢性肝纤维化经验[J]. 中华中医药杂志, 2007, 22(3): 168-171.
[16]	李腾飞, 蒋明芹. 中医药治疗慢性乙型肝炎研究进展[J]. 中国中医药现代远程教育, 2021, 19(21): 206-208.
[17]	姚希贤, 房红梅, 王军民. 拆方益肝康与药物血清对肝星状细胞PDGF及受体表达的影响[J]. 世界华人消化杂志, 2005, 13(12): 1412-1416.
[18]	王凤龙, 刘员, 张来宾, 等. 当归抗炎镇痛作用研究进展[J]. 中国实验方剂学杂志, 2021, 27(15): 197-209.
[19]	楚永庆, 李桃桃, 陈霞, 等. 李东垣学术思想及《脾胃论》用药规律浅析[J]. 浙江中医药大学学报, 2021, 45(7): 792-796.
[20]	Yao XX, Cui DL, Sun YF, et al. Study on the Anti-Liver Fibrosis Effect of Benefit Liver Granule(益肝冲剂)and Its Mechanism in Rats[J]. Chin J Integr Med, 2002, 8(2): 118-121.
[21]	苏春芝, 杨倩, 张金丽, 等. "化浊调肝健脾"法对乙型肝炎病毒相关性肝硬化指标影响的临床研究[J]. 中国中西医结合消化杂志, 2024, 32(2): 115-119. doi: 10.3969/j.issn.1671-038X.2024.02.05
[22]	张金丽, 苏飞, 张焕婷, 等. 化浊解毒调肝方对乙型肝炎大鼠肝纤维化、免疫功能及Ras/ERK信号通路的影响[J]. 中西医结合肝病杂志, 2024, 34(5): 409-413.